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Objective: To report two cases of methemoglobinemia induced by inhaled nitrobenzene and dermally
absorbed aniline.
Methods: We have evaluated a 37-year-old male worker exposed to nitrobenzene by inhalation while conducting
maintenance job of mononitrobenzene pump and a 25-year-old male worker exposed dermally to aniline while
unloading.
Results: The first case is a 37-year-old male exposed to nitrobenzene. His blood methemoglobin concentration level
was initially 19.8%, and chest X-ray was normal. After oxygen therapy, the blood methemoglobin concentration
level decreased to 2.1%, and the symptoms were alleviated. The second case is a 25-year-old male exposed
dermally to aniline. His chest X-ray was normal, but blood methemoglobin concentration level reached maximally
46.8%. He was treated with methylene blue due to relatively high blood methemoglobin level. Gradually after the
treatment, his methemoglobin concentration level was normalized to 0.8% and simultaneously symptoms were
resolved.
Conclusions: After the thorough exposure investigations and medical evaluations, we have concluded that these
cases were methemoglobinemia induced by occupational exposure to nitrobenzene and aniline. We suggest that
businesses which handle methemoglobinemia-causing substances control the engineering process strictly,
implement periodic screening, and establish emergency patient management system.
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Methemoglobin (MetHb) is a modified form of normal
hemoglobin where Fe2+ (ferrous ion) is oxidized into Fe3+
(ferric ion). MetHb cannot bind with oxygen, and hence it
cannot carry oxygen. The human body can tolerate a very
small amount (less than 1%) of MetHb, but a higher level
is likely to cause methemoglobinemia [1-4].
Methemoglobinemia can be both inherited and acquired.
Methemoglobinemia is commonly caused by exposure to
medical substances, such as benzocaine and dapsone, that
oxidize hemoglobin to MetHb; exhaust fumes from internal
combustion engines; herbicides and pesticides; and chemi-
cals, such as nitrobenzene and aniline [5-11]. Nitrobenzene
and aniline are typical aromatic nitro compounds and aro-
matic amino compounds that cause methemoglobinemia.* Correspondence: jdmoon@chol.com
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stated.Nitrobenzene is mostly used in the synthesis of aniline and
in the production of benzidine, quinolone, and azobenzene
[12]. Nitrobenzene is a pale yellow liquid, which has an
almond-like odor at room temperature. The most common
paths of occupational exposure to nitrobenzene are inhal-
ation and absorption through the skin [12-15]. The reduc-
tion of nitrobenzene to aniline occurs once nitrobenzene is
metabolized within the body, and this process oxidizes the
hemoglobin in the blood into MetHb, which then causes
methemoglobinemia [1,14].
Aniline is a prototypical aromatic amine in a pale yellow
liquid form with an unpleasant odor of rotten fish. It is used
in the production of dyes, rubber processing chemicals, and
antioxidants [16]. The most common occupational expos-
ure to aniline includes inhalation, oral ingestion, and ab-
sorption through the skin. Hydroxylamine compounds,
such as phenylhydroxylamine, are known to cause
methemoglobinemia when they begin oxidation [17-19].. This is an Open Access article distributed under the terms of the Creative
ommons.org/licenses/by/2.0), which permits unrestricted use, distribution, and
iginal work is properly cited. The Creative Commons Public Domain Dedication
ain/zero/1.0/) applies to the data made available in this article, unless otherwise
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Past medical history and/or family history
Nothing significant.
History of cigarette smoking and alcohol consumption
Nonsmoker, rarely drinks.
Occupational history
The patient works in methylene diphenyl diisocyanate
(MDI) production (Figure 1). Prior to experiencingFigure 1 Schematic diagram showing the principal operations leadingsymptoms, the patient had been cleaning a suction strainer
of a mononitrobenzene pump for six to seven hours. The
process of cleaning a suction strainer starts from opening the
cover of the strainer, taking out the screen that is inside, re-
moving impurities and foreign substances, and then reassem-
bling the strainer. It is likely that the patient was exposed to
mononitrobenzene through inhalation during this process.
History of present illness
The patient displayed no symptoms while cleaning the suc-
tion strainer of the mononitrobenzene pump, but he expe-
rienced dyspnea and cyanoderma shortly after he returned
home after work. He was immediately taken to the local
hospital. As he showed no improvement after emergency
treatment, including oxygen inhalation therapy, he was
transferred to the emergency room after consulting the De-
partment of Occupational & Environmental Medicine of an
affiliated university hospital in accordance with the emer-
gency patient management guidelines of the workplace.
Physical findings
At the time of transfer, his blood pressure was 110/
70 mmHg, his pulse rate was 88 beats per minute, histo the production of MDI.
Table 1 Progress of blood gas analysis and
methemoglobin concentration of case 1
Initial Progress*
2 hours later 1 day later
pH 7.41 7.45 7.41
PCO₂ (mmHg) 35.6 35.2 39.2
PO₂ (mmHg) 161 155 86.3
HCO₃− (mmol/L) 21.9 24.3 24.5
O₂ saturation (%) 97.8 98.1 95.6
Methemoglobin (%) 19.8 12.7 2.1
*The patient was treated with O₂ inhalation via mask(10 L/min).
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temperature was 36.8°C. Although acutely ill, there was no
sign of severe cyanoderma anywhere on his body. There
were no findings of jaundice in the sclera or conjunctiva
pallor according to a head and neck examination. Heart
sounds were regular, with no abnormal murmurs. Respira-
tory sounds were also normal. There were no significant
symptoms found in the abdominal region.
Laboratory findings
A peripheral blood examination revealed the following:
hemoglobin level 15.3 g/dl, hematocrit 43.6%, white blood
cells 7,500/mm3, and platelet count 188,000/mm3. Accord-
ing to a biochemical examination, blood urea nitrogen
(BUN) was 14.7 mg/dL, creatinine was 1.0 mg/dL, asparate
aminotransferase (AST) was 19 IU/L, and alanine amino-
transferase (ALT) was 18 IU/L. Urine test results were nor-
mal. An arterial blood gas examination revealed a pH of
7.41, PCO2 of 35.6 mmHg, PO2 of 161 mmHg, HCO3
− of
21.9 mmol/L, O2 saturation of 97.8%, O2Hb (oxidized
hemoglobin) of 78.6%, and MetHb of 19.8%.
Electrocardiogram findings
An electrocardiogram showed sinus rhythm, but the pa-
tient’s heart rate was 60 beats per minute, which was a
possible sign of sinus bradycardia.
Medical imaging findings
There were no significant findings on plain chest radiog-
raphy and chest computed tomography.
Clinical course
The patient was diagnosed with methemoglobinemia ac-
cording to the medical test results and his past exposure
history to mononitrobenzene. As his MetHb levels were
relatively low, he was given simple O2 inhalation treatment
through a mask at 10 L per minute. Two hours after the
treatment, his MetHb was reduced to 12.7%, and his symp-
toms were alleviated. On his second day of hospitalization,
his pH was 7.41, and PCO2 was 39.2 mmHg, PO2 was
86.3 mmHg, HCO3
− was 24.5 mmol/L, O2 saturation was
95.6%, and MetHb was 2.1% according to an arterial
blood gas examination (Table 1). The symptoms of
methemoglobinemia, including dyspnea and cyano-
derma, disappeared, and he was discharged from the





Signs of cyanoderma appeared one hour and thirty mi-
nutes after exposure to aniline.Past medical history and/or family history
Nothing significant.
History of cigarette smoking and alcohol consumption
Smoker of 2.5 pack-year, occasionally consumes alcohol
Occupational history
The patient works in the MDI production field and is in
charge of loading and unloading aniline from bulk
trucks. He was exposed to aniline while removing a con-
nector from the tank of a lorry. Approximately 200 cc of
aniline that remained in the vent line spattered on his
face and his upper body.
History of present illness
Following the exposure to the aniline, the patient was
taken to a local hospital for emergency treatment and ob-
servation. He did not show any immediate symptoms
other than pain caused by a burn around the exposed area.
However, after O2 inhalation treatment (5 L/min via an
O2 mask), he showed cyanoderma on his entire body, in-
cluding his face. An arterial blood gas examination re-
vealed O2 saturation was reduced from 91% to 89%. The
MetHb reading was 26.3%. The patient was transferred to
the emergency room after consulting the Department of
Occupational & Environmental Medicine of an affiliated
university hospital in accordance with the emergency pa-
tient management guidelines of the workplace.
Physical findings
At the time of transfer, his blood pressure was 130/
80 mmHg, his pulse rate was 80 beats per minute, his re-
spiratory rate was 20 breaths per minute, and his body
temperature was 36.0°C. He was acutely ill and showed
signs of cyanoderma on his entire body. A head and neck
examination showed no findings of jaundice in the sclera or
conjunctiva pallor. However, both eyelids showed signs of
rubefaction (Figure 2). Heart sounds were regular, with no
abnormal murmurs. Respiratory sounds were also normal,
but the left side of his chest was red. There were no signifi-
cant symptoms found in the abdominal region. Redness
(B)(A)
Figure 2 Skin irritation of upper and lower eyelids of both sides. (A) Left eyelids. (B) Right eyelids.
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of his elbows (Figure 3).
Laboratory findings
A peripheral blood examination showed the following:
hemoglobin level 14.4 g/dl, hematocrit 41.7%, white blood
cells 6,800/mm3, and platelet count 218,000/mm3. Accord-
ing to a biochemical examination, his BUN was 13.4 mg/dL,
creatinine was 0.6 mg/dL, AST was 19 IU/L, and ALT was
18 IU/L. Urine test results were normal. According to the
arterial blood gas examination, his pH was 7.41, PCO2
was 37.4 mmHg, PO2 was 185 mmHg, HCO3
− was
23.0 mmol/L, O2 saturation was 98.3%, O2Hb (oxidized
hemoglobin) was 51.9%, and MetHb was 46.8%.Electrocardiogram findings
An electrocardiogram showed a sinus rhythm and a
regular heart rate (65 beats per minute).Medical imaging findings
There were no significant findings on plain chest
radiography.(A)
Figure 3 Skin lesions of antecubital fossa of both arms. (A) Left antecuClinical course
Based on the patient’s medical test results, MetHb level,
and exposure history to aniline, the patient was diagnosed
with methemoglobinemia. He was given O2 inhalation
treatment (10 L/min via a mask) and 7 ml of 2% methylene
blue diluted in 100 ml of saline solution. His MetHb was
25.3%, 19.3%, 9.9%, and 6.6% at one, two, four, and six
hours, respectively after the treatment. According to an ar-
terial blood gas examination on the second day of his
hospitalization, his pH was 7.34, PCO2 was 47.2 mmHg,
PO2 was 237 mmHg, HCO3
− was 25.0 mmol/L, O2 satur-
ation was 99.0%, and MetHb was 2.4%. The symptoms
caused by the methemoglobinemia, such as cyanoderma,
gradually improved. An ointment was applied to skin le-
sions (primary burns and contact dermatitis) caused by an-
iline. Eye drops were applied for cornea inflammation.
According to an arterial blood gas examination on his
fourth day of hospitalization, his pH was 7.46. PCO2
was 34.1 mmHg, PO2 was 119 mmHg, HCO3
− was
24.2 mmol/L, O2 saturation was 97.2%, and MetHb was
0.8% (Table 2). The level of MetHb returned to normal.
The symptoms of methemoglobinemia were gradually al-
leviated, and he was discharged from the hospital at 2 pm
on the seventh day of hospitalization.(B)
bital fossa. (B) Right antecubital fossa.
Table 2 Progress of blood gas analysis and methemoglobin concentration of case 2
Initial* Progress†
1 hour later 2 hours later 4 hours later 6 hours later 1 day later 2 days later 3 days later
pH 7.41 7.40 7.40 7.36 7.34 7.34 7.42 7.46
PCO₂ (mmHg) 37.4 41.3 38.1 43.5 45.0 47.2 39,1 34.1
PO₂ (mmHg) 185 221 200.9 261.1 345 237 114 119
HCO₃− (mmol/L) 23.0 23.5 23.1 24.2 23.6 25.0 25.0 24.2
O₂ saturation (%) 98.3 98.5 98.6 99.0 99.2 99.0 98.3 97.2
Methemoglobin (%) 46.8 25.3 19.3 9.9 6.6 2.4 1.5 0.8
*The MetHb at the local hospital was 26.3%.
†The patient was initially treated with injection of 2% methylene blue and O₂ inhalation.
Lee et al. Annals of Occupational and Environmental Medicine 2013, 25:31 Page 5 of 7
http://www.aoemj.com/content/25/1/31Conclusions
As mentioned above, the majority of acquired meth-
emoglobinemia occurs through nonoccupational expos-
ure. Several cases of occupational exposure have been
reported during repair and maintenance in production of
aniline, medical substances, pesticides, and rubber. Occu-
pational exposure has also occurred during transportation
and disposal of substances that cause methemoglobinemia
[1,5]. In addition to being uncommon, such exposure is
rarely fatal.
Hemoglobin is oxidized into MetHb via three main
mechanisms, depending on the source of exposure. Direct
oxidization of hemoglobin occurs in response to exposure
to specific substances, such as copper (II) sulfate and hexa-
valent chromates. It relies on the redox potential of the
substance relative to hemoglobin. Indirect oxidation of
hemoglobin, for example, by nitrites and phenylenedi-
amine, relies on a co-oxidation mechanism. Lastly, there
are cases where the substance itself is not sufficient to cre-
ate MetHb. In such cases, MetHb is created following ex-
posure to specific metabolic activities in the body and
subsequent biochemical changes. The occupational expos-
ure cases reported herein where the workers were exposed
to aniline and nitrobenzene fall into this category [1].
Occupational exposure to nitrobenzene occurs via inhal-
ation and absorption through the skin. Once it is absorbed,
nitrobenzene is metabolized into nitrosobenzene, which is
toxic and causes methemoglobinemia [1,14,20]. According
to international and domestic studies on nitrobenzene ad-
diction, most exposure takes place via ingestion and ab-
sorption through the skin [13-15,21-23].
In the first case, the worker developed symptoms after
cleaning a suction strainer of a mononitrobenzene pump
for six or seven hours, but he showed no signs of exposure
through ingestion or absorption through the skin. The
time-weighted average (TWA) of nitrobenzene exposure
regulation in Korea is 1 ppm. Markers of nitrobenzene ex-
posure include urinary p-nitrophenol and the aniline con-
centration level in the blood, but these are nonspecific
markers [14,20,24]. One limitation of the current study
was the absence of a direct evaluation of the workenvironment. However, because the worker had no prior
drug history or exposure to other chemicals that could
have caused methemoglobinemia, his exposure to nitro-
benzene during the work process was clear. In addition, as
MetHb is often used as a biomarker of nitrobenzene ex-
posure, his methemoglobinemia was diagnosed to be
caused by exposure to nitrobenzene.
It is known that occupational exposure to aniline can
occur via inhalation through respiratory organs, oral in-
gestion, and absorption through the skin and that aniline
causes methemoglobinemia following oxidation via phenyl
hydroxylamine, a metabolite [1,14,17-19]. According to
prior cases of aniline exposure, the majority of cases in-
volved oral ingestion and inhalation through the respira-
tory organs [17-19].
In the second case, the worker was removing a con-
nector from the tank of an aniline lorry when approxi-
mately 200 cc of aniline remaining in the vent line
spattered on his face and his upper body. Although the
possibility of inhalation cannot be ignored, it can be as-
sumed that the major exposure to aniline was absorption
through the skin. The TWA of aniline exposure regulation
in Korea is 2 ppm, and urinary p-aminophenol is used as
a biomarker [19,24]. The worker in this case had no
prior intake history of drugs that may have caused the
methemoglobinemia, and his methemoglobinemia was di-
agnosed as due to exposure to aniline.
The diagnosis of methemoglobinemia is based on the re-
sults of an arterial blood gas examination and measure-
ments of the concentration of MetHb in the blood [1].
The symptoms of methemoglobinemia differ depending
on the concentration level of MetHb in the blood, with 0–
20% potentially producing cyanoderma; 20–40% poten-
tially producing headache, anxiety, vertigo, and a frequent
pulse; 40–60% potentially producing clouding of con-
sciousness and respiratory failure; and more than 60% po-
tentially resulting in arrhythmia, convulsion, and even
death [1,5].
Discontinued exposure to the substance, oxygen ther-
apy, and intravenous injection of methylene blue are some
of the options for methemoglobinemia [1,5,25-27]. Under
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MetHb in their bodies. In that case, hemoglobin convert
to MetHb and MetHb revert to hemoglobin interactively.
MetHb may revert to hemoglobin via a reaction involving
nicotinamide dinucleotide hydrogenase (NADH) and
nicotinamide-adenine dinucleotide phosphate hydrogen-
ase (NADPH). In living tissue, most MetHb is reduced
through NADH-dependent reactions rather than via
NADPH-dependent reactions. Methylene blue combats
methemoglobinemia by activating NADPH reactions and
accelerating the reduction process of MetHb [1,4,5].
Methylene blue treatment is applicable when a patient’s
MetHb exceeds 25–30% or when the patient exhibits
symptoms of oxygen deficiency, such as dyspnea and alter-
ation of consciousness [1,22].
In the first of the presented cases, oxygen treatment
alone improved the patient’s symptoms and led to a de-
crease in his MetHb because his initial MetHb level was
19.8%. In the second case, methylene blue treatment was
required because the patient’s MetHb level was 46.8%,
and his symptoms improved after the treatment.
The final clinical progress of both workers was positive.
According to other reports of occupational exposure to
substances that cause methemoglobinemia, fatal outcomes
are rare [1]. However, methemoglobinemia is caused by
various substances. If specific exposure paths are not diag-
nosed and understood, early stages of treatment may not
be sufficient or appropriate. In extreme cases, this could
lead to death. The worker in Case 2 showed no fatal symp-
toms in the beginning but developed cyanoderma and in-
creased MetHb levels close to 50% as time passed. This
case highlights the need for all workers who handle
methemoglobinemia-causing substances to be provided
with access to a medical institution with plenty of experi-
ence in occupational and environmental medicine.
Ultimately, methemoglobinemia-causing substances,
such as nitrobenzene and aniline, can be absorbed by
workers at petrochemical plants in various ways, and
symptoms may not appear for a few hours after exposure.
Businesses that handle such substances must have a strict
maintenance system in place, as well as a protection sys-
tem for workers, including regular exposure check-ups
and an emergency patient management system to ensure
that all workers have access to timely diagnosis and treat-
ment at an affiliated medical institution.Consent
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